Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF

Brain Research

Volumn 621, Issue 1, 1993, Pages 35-49

  Mattson, Mark P ^a   Tomaselli, Kevin J ^b   Rydel, Russell E ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Athena Neurosciences Inc   (United States)

Author keywords

Alzheimer's disease; Fura 2; Glutamate; Hippocampus; Nerve growth factor; Neurotoxicity

Indexed keywords

AMYLOID BETA PROTEIN; FIBROBLAST GROWTH FACTOR; FURA 2; NERVE GROWTH FACTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; FETUS; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN; ANIMAL; CALCIUM; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; HIPPOCAMPUS; HOMEOSTASIS; NERVE DEGENERATION; NEURONS; NEUROPEPTIDES; RATS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027297138     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(93)90295-X     Document Type: Article

References (69)

1. Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo
2. Alzheimer's disease amyloid β protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum
3. Solution structures of β peptide and its constituent fragments: relation to amyloid deposition
4. Release of a putative 60-kDa amyloidogenic Alzheimer amyloid precursor protein from PC-12 cells, and the isolation of AD-fibroblast hybrids
5. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs
6. Methodological variables in the assessment of beta amyloid neurotoxicity
7. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis
8. Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF
9. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage
10. Glutamate neurotoxicity and diseases of the nervous system
11. 2+ exchange activity is increased in Alzheimer's disease brain tissues
12. β-Amyloid increases neuronal susceptibility to injury by glucose deprivation
13. Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease
14. Cleavage of amyloid β peptide during constitutive processing of its precursor
15. Bovine brain astrocytes express basic fibroblast growth factor, a neurotropic and angiogenic mitogen
16. Increased basic fibroblast growth factor (bFGF) immunoreactivity at the site of focal brain wounds
17. Senile plaques as aberrant sprout-stimulating structures
18. Calcium and the aging nervous system
19. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein
20. Processing of the amyloid protein precursor to potenially amyloidogenic derivatives
21. Excitatory amino acids and Alzheimer's disease
22. Targeting of cell surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments
23. Amyloid β-peptide is produced by cultured cells during normal metabolism
24. Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases
25. Analysis and quantification of the β-amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients with a monoclonal antibody-based immunoassay
26. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease
27. Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type?
28. Specific reduction of calcium binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative disorders
29. Immunocytochemical demonstration of fibroblast growth factor in cultured chick and rat neurons
30. 11AT antitrypsin-protease complexes for binding to the serpin-enzyme complex (SEC) receptors
31. Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer's disease
32. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
33. β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage
34. Cloning of cDNA for the glutamate-binding subunit of an NMDA receptor complex
35. Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and calcium influx in cultured hippocampal neurons
36. Calcium as sculptor and destroyer of neural circuitry
37. Outgrowth-regulating actions of glutamate in isolated hippocampal pyramidal neurons
38. Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture
39. 2+ extrusion in protection against neuronal excitotoxicity
40. Glia protect hippocampal neurons against excitatory amino acid-induced degeneration: involvement of fibroblast growth factor
41. Effects of elevated intracellular calcium levels on the cytoskeleton and tau in cultured human cerebral cortical neurons
42. Developmental expression, compartmentalization, and possible role in excitotoxicity of a putative NMDA receptor protein in cultured hippocampal neurons
43. Evidence for calcium-reducing and excitoprotective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons
44. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
45. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of β-amyloid precursor protein
46. Amyloid β protein substituent peptides do not interact with the substance P receptor expressed in cultured cells
47. The Alzheimer amyloid precursor protein
48. Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease
49. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimers disease
50. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity
51. Fibroblast growth factor induces beta-amyloid precursor mRNA in glial but not neuronal cultured cells
52. Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation
53. Biochemistry of altered brain proteins in Alzheimer's disease
54. Isolation and quantitation of soluble Alzheimer's β-peptide from biological fluids
55. Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide
56. Production of the Alzheimer amyloid β protein by normal proteolytic processing
57. Amelioration of delayed neuronal death in the hippocampus by nerve growth factor
58. Basic fibroblast growth factor binding is a marker for extracellular neurofibrillary tangles in Alzheimer disease
59. Calcium, excitotoxins, and neuronal death in the brain
60. Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing
61. Early accumulation of heparan sulfate in neurons and in the beta amyloid protein containing lesions in Alzheimer's disease and Down's syndrome
62. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of glutathione system
63. Identification of a stable fragment of the Alzheimer amyloid precursor containing the β-protein in brain microvessels
64. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein
65. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides
66. Nerve growth factor potentiates the neurotoxicity of β amyloid
67. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
68. On the interaction of a synthetic Alzheimer β-amyloid peptide with NB41A3 cells